Delivery Order SPE2DR25D9127-SPE2DR26FDAB5
Award Date 5/6/26
Potential Completion Date 5/7/26
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 28, 2026, with a ceiling value of $25,165.90 for JAKAFI 15 MG tablets (60-count supply). DMS Pharmaceutical is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, with a ceiling value of $12,582.95 for JAKAFI 15 mg tablets (60-count supply). The order is firm fixed price with an ultimate completion date of March 17, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor...
- The Defense Logistics Agency issued a $12,603.07 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 25, 2026, for JAKAFI 25 mg tablets (60-count unit). The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 5, 2026, for JAKAFI 5 mg tablets (60-count units) with a ceiling value of $38,162.76. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business headquartered in Park Ridge, Illinois, the sole...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, with a ceiling value of $12,663.27 for JAKAFI 10 mg tablets (60-count units), ultimate completion by March 10, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical...
- The Defense Logistics Agency issued a $50,356.44 delivery order to DMS Pharmaceutical Group Inc. on May 4, 2026, for JAKAFI 20 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed under the single-award indefinite delivery contract SPE2DX, a $499.999 billion Defense Logistics Agency pharmaceutical prime vendor contract running through December 31, 2036. Place of performance...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for JAKAFI 10 mg tablets (60-count units) with a ceiling value of $37,989.81 and an ultimate completion date of March 6, 2026. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion vehicle established to supply...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 30, 2026, with a ceiling value of $12,589.11 for JAKAFI 20 mg tablets (60-count supply), with ultimate completion on May 1, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract vehicle. DMS Pharmaceutical Group Inc. is a woman-owned small business headquartered in Park Ridge, Illinois,...
- The Defense Logistics Agency issued a $25,441.84 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, for JAKAFI 5 mg tablets (60-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical is a woman-owned small business serving as the sole regional prime vendor under PPV-G GEN V, a $30.3 billion Defense Logistics Agency acquisition strategy for branded and generic prescription drugs, biologics, over-the-counter medications, vaccines,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 1, 2026, for JAKAFI 15 mg tablets with a ceiling value of $25,165.90 and ultimate completion date of April 2, 2026. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award indefinite delivery contract. Place of performance is Park Ridge, IL. DMS Pharmaceutical Group,...